{
    "nctId": "NCT01483196",
    "briefTitle": "Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery",
    "officialTitle": "Feasibility Study of Vascular and Cognitive Assessments During Adjuvant Chemotherapy for Breast Cancer (VASCOG)",
    "overallStatus": "COMPLETED",
    "conditions": "Cognitive/Functional Effects, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Participation rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must have histologically or cytologically confirmed non-metastatic breast cancer; stages 1-3 are acceptable\n* Patients must be candidates for either neoadjuvant or adjuvant chemotherapy for breast cancer\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Patients who have had prior systemic chemotherapy are not eligible for the study\n* Patients who are scheduled to receive trastuzumab and/or bevacizumab are not eligible\n* Patients who are on dialysis\n* Women who are pregnant are not eligible due to unknown risks and potential harm to the unborn fetus\n* Patients with metastatic breast cancer are not eligible",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}